Global Eye Infections Treatment Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 102

Report ID: 3591

Eye infections can be the inflammation of the Conjunctiva (Conjunctivitis), eyelid (blepharitis), the cornea (keratitis), the liquid inside the eye (vitritis), the retina and the blood vessels that feed it (chorioretinitis), or the optic nerve (neuroretinitis).
Eye infections treatment market is growing, this is attributed to aging population, rising prevalence of ophthalmic diseases, increasing company investments for launching new product forms, health conscious population, free eye check-up camps funded by the government in the different regions.
Eye infection treatment market highest share is of United States followed by Europe owing to technological advancement and large industry pool in these geography.
Asia-Pacific market is expected to register higher growth owing to the rise in geriatric population and also the rise in prevalence of blindness in geriatric population.
In 2018, the global Eye Infections Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Eye Infections Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Eye Infections Treatment development in United States, Europe and China.

The key players covered in this study
Roche
Allergan
Mercks
Novartis
Pfizer
Santen Pharmaceuticals
Valent
Bayer
GSK
AstraZeneca
Daiichi Sankyo
Eli Lilly
Novo Nordisk
Sanofi
GSK
Bausch&Lomb

Market segment by Type, the product can be split into
Gels & Creams
Eye drops
Drug

Market segment by Application, split into
Ophthalmology Clinics
Hospitals
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Eye Infections Treatment status, future forecast, growth opportunity, key market and key players.
To present the Eye Infections Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Eye Infections Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Eye Infections Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Gels & Creams
1.4.3 Eye drops
1.4.4 Drug
1.5 Market by Application
1.5.1 Global Eye Infections Treatment Market Share by Application (2014-2025)
1.5.2 Ophthalmology Clinics
1.5.3 Hospitals
1.5.4 Retail Pharmacies
1.5.5 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Eye Infections Treatment Market Size
2.2 Eye Infections Treatment Growth Trends by Regions
2.2.1 Eye Infections Treatment Market Size by Regions (2014-2025)
2.2.2 Eye Infections Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Eye Infections Treatment Market Size by Manufacturers
3.1.1 Global Eye Infections Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Eye Infections Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Eye Infections Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Eye Infections Treatment Key Players Head office and Area Served
3.3 Key Players Eye Infections Treatment Product/Solution/Service
3.4 Date of Enter into Eye Infections Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Eye Infections Treatment Market Size by Type (2014-2019)
4.2 Global Eye Infections Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Eye Infections Treatment Market Size (2014-2019)
5.2 Eye Infections Treatment Key Players in United States
5.3 United States Eye Infections Treatment Market Size by Type
5.4 United States Eye Infections Treatment Market Size by Application

6 Europe
6.1 Europe Eye Infections Treatment Market Size (2014-2019)
6.2 Eye Infections Treatment Key Players in Europe
6.3 Europe Eye Infections Treatment Market Size by Type
6.4 Europe Eye Infections Treatment Market Size by Application

7 China
7.1 China Eye Infections Treatment Market Size (2014-2019)
7.2 Eye Infections Treatment Key Players in China
7.3 China Eye Infections Treatment Market Size by Type
7.4 China Eye Infections Treatment Market Size by Application

8 Japan
8.1 Japan Eye Infections Treatment Market Size (2014-2019)
8.2 Eye Infections Treatment Key Players in Japan
8.3 Japan Eye Infections Treatment Market Size by Type
8.4 Japan Eye Infections Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Eye Infections Treatment Market Size (2014-2019)
9.2 Eye Infections Treatment Key Players in Southeast Asia
9.3 Southeast Asia Eye Infections Treatment Market Size by Type
9.4 Southeast Asia Eye Infections Treatment Market Size by Application

10 India
10.1 India Eye Infections Treatment Market Size (2014-2019)
10.2 Eye Infections Treatment Key Players in India
10.3 India Eye Infections Treatment Market Size by Type
10.4 India Eye Infections Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Eye Infections Treatment Market Size (2014-2019)
11.2 Eye Infections Treatment Key Players in Central & South America
11.3 Central & South America Eye Infections Treatment Market Size by Type
11.4 Central & South America Eye Infections Treatment Market Size by Application

12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Eye Infections Treatment Introduction
12.1.4 Roche Revenue in Eye Infections Treatment Business (2014-2019)
12.1.5 Roche Recent Development
12.2 Allergan
12.2.1 Allergan Company Details
12.2.2 Company Description and Business Overview
12.2.3 Eye Infections Treatment Introduction
12.2.4 Allergan Revenue in Eye Infections Treatment Business (2014-2019)
12.2.5 Allergan Recent Development
12.3 Mercks
12.3.1 Mercks Company Details
12.3.2 Company Description and Business Overview
12.3.3 Eye Infections Treatment Introduction
12.3.4 Mercks Revenue in Eye Infections Treatment Business (2014-2019)
12.3.5 Mercks Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Eye Infections Treatment Introduction
12.4.4 Novartis Revenue in Eye Infections Treatment Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Eye Infections Treatment Introduction
12.5.4 Pfizer Revenue in Eye Infections Treatment Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Santen Pharmaceuticals
12.6.1 Santen Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Eye Infections Treatment Introduction
12.6.4 Santen Pharmaceuticals Revenue in Eye Infections Treatment Business (2014-2019)
12.6.5 Santen Pharmaceuticals Recent Development
12.7 Valent
12.7.1 Valent Company Details
12.7.2 Company Description and Business Overview
12.7.3 Eye Infections Treatment Introduction
12.7.4 Valent Revenue in Eye Infections Treatment Business (2014-2019)
12.7.5 Valent Recent Development
12.8 Bayer
12.8.1 Bayer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Eye Infections Treatment Introduction
12.8.4 Bayer Revenue in Eye Infections Treatment Business (2014-2019)
12.8.5 Bayer Recent Development
12.9 GSK
12.9.1 GSK Company Details
12.9.2 Company Description and Business Overview
12.9.3 Eye Infections Treatment Introduction
12.9.4 GSK Revenue in Eye Infections Treatment Business (2014-2019)
12.9.5 GSK Recent Development
12.10 AstraZeneca
12.10.1 AstraZeneca Company Details
12.10.2 Company Description and Business Overview
12.10.3 Eye Infections Treatment Introduction
12.10.4 AstraZeneca Revenue in Eye Infections Treatment Business (2014-2019)
12.10.5 AstraZeneca Recent Development
12.11 Daiichi Sankyo
12.12 Eli Lilly
12.13 Novo Nordisk
12.14 Sanofi
12.15 GSK
12.16 Bausch&Lomb

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details